Time to rethink corticosteroids for COPD
This content has been produced by Australian Doctor Group with an independent educational grant from Boehringer Ingelheim.
Australian and international experts and guidelines are urging a rethink of the use of inhaled corticosteroids in patients with COPD, arguing that bronchodilators are the cornerstone of therapy.1–5
This infographic addresses GPs’ common questions about COPD treatment recommendations.
References: 1. Jenkins C. Aust Prescr 2017; 40: 15